• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人甲状腺癌细胞中HLA - DR表达与聚(ADP - 核糖)合成酶水平的相关性

Correlation between HLA-DR expression and level of poly(ADP-ribose) synthetase in human thyroid carcinoma cells.

作者信息

Shinohara M, Morisawa K, Ota K, Qu Z, Takeda K, Hashimoto K, Tomoda T, Kurashige T, Taniguchi T

机构信息

Department of Pediatrics, Kochi Medical School, Japan.

出版信息

Cell Mol Biol (Noisy-le-grand). 1997 Mar;43(2):227-35.

PMID:9130606
Abstract

The expression of MHC class II molecules is normally restricted to antigen presenting cells. Aberrant expression of class II molecules, however, was detected in the thyrocytes of autoimmune thyroid diseases. We attempted to regulate the expression of HLA-DR molecules in thyroid carcinoma cells by expressing the exogenous poly(ADP-ribose) synthetase gene. We transfected a metal inducible expression plasmid capable of expressing poly(ADP-ribose) synthetase gene into thyroid carcinoma 8505C cells and the transformants, treated with metal and IFN-gamma, were separated by Magnetic Cell Separation. The activity of the synthetase was increased in the HLA-DR-enriched transformants as compared with that in control or the HLA-DR+ transformants. RNA blot analysis and flow cytometric analysis revealed that the IFN-gamma-inducible expression of HLA-DR molecules was depressed by the induction of exogenous poly(ADP-ribose) synthetase gene. This result indicates that HLA-DR expression was correlated with the level of poly(ADP-ribose) synthetase in human thyroid carcinoma cells. Furthermore we examined the level of poly(ADP-ribose) synthetase in patients with autoimmune thyroid diseases. We observed a significant decrease in poly(ADP-ribose) synthetase in the patients. Taken together with the previous observation, the decrease in poly(ADP-ribose) synthetase is closely linked to the aberrant expression of HLA-DR molecules in some autoimmune thyroid diseases.

摘要

MHC II类分子的表达通常局限于抗原呈递细胞。然而,在自身免疫性甲状腺疾病的甲状腺细胞中检测到了II类分子的异常表达。我们试图通过表达外源性聚(ADP-核糖)合成酶基因来调节甲状腺癌细胞中HLA-DR分子的表达。我们将能够表达聚(ADP-核糖)合成酶基因的金属诱导表达质粒转染到甲状腺癌8505C细胞中,并用金属和干扰素-γ处理转化体,通过磁性细胞分离法进行分离。与对照或HLA-DR+转化体相比,富含HLA-DR的转化体中合成酶的活性增加。RNA印迹分析和流式细胞术分析表明,外源性聚(ADP-核糖)合成酶基因的诱导抑制了干扰素-γ诱导的HLA-DR分子表达。该结果表明,在人甲状腺癌细胞中HLA-DR的表达与聚(ADP-核糖)合成酶的水平相关。此外,我们检测了自身免疫性甲状腺疾病患者体内聚(ADP-核糖)合成酶的水平。我们观察到患者体内聚(ADP-核糖)合成酶显著降低。结合之前的观察结果,聚(ADP-核糖)合成酶的降低与某些自身免疫性甲状腺疾病中HLA-DR分子的异常表达密切相关。

相似文献

1
Correlation between HLA-DR expression and level of poly(ADP-ribose) synthetase in human thyroid carcinoma cells.人甲状腺癌细胞中HLA - DR表达与聚(ADP - 核糖)合成酶水平的相关性
Cell Mol Biol (Noisy-le-grand). 1997 Mar;43(2):227-35.
2
Participation of poly(ADP-ribose) synthetase in the process of norepinephrine-induced inhibition of major histocompatibility complex class II antigen expression in human astrocytoma cells.聚(ADP - 核糖)合成酶在去甲肾上腺素诱导的人星形细胞瘤细胞主要组织相容性复合体II类抗原表达抑制过程中的参与情况。
Biochem Biophys Res Commun. 1993 Jun 30;193(3):886-9. doi: 10.1006/bbrc.1993.1708.
3
Enhancement of interferon-gamma-induced major histocompatibility complex class II gene expression by expressing an antisense RNA of poly(ADP-ribose) synthetase.通过表达聚(ADP-核糖)合成酶的反义RNA增强干扰素-γ诱导的主要组织相容性复合体II类基因表达。
J Biol Chem. 1994 Feb 25;269(8):5543-7.
4
Control of HLA-DR antigen expression by gamma-interferon: separate signal transduction mechanisms in malignant and nonmalignant human thyroid cells.γ干扰素对HLA-DR抗原表达的调控:恶性和非恶性人甲状腺细胞中的不同信号转导机制
Cancer Res. 1993 Sep 1;53(17):3943-7.
5
[Spontaneous expression of class II (HLA-DR) molecules in thyroid pathology].[甲状腺病理学中II类(HLA - DR)分子的自发表达]
Rev Med Chil. 1991 Aug;119(8):867-70.
6
Regulation of HLA-DR and costimulatory B7 molecules in human thyroid carcinoma cells: differential binding of transcription factors to the HLA-DRalpha promoter.人甲状腺癌细胞中HLA-DR和共刺激分子B7的调控:转录因子与HLA-DRα启动子的差异结合
Thyroid. 1998 May;8(5):361-9. doi: 10.1089/thy.1998.8.361.
7
Inhibition of interferon-gamma- and phorbol ester-induced HLA-DR and interleukin-1 production by the expression of a transfected poly(ADP-ribose) synthetase gene in human leukemia THP-1 cells.在人白血病THP - 1细胞中,通过转染的聚(ADP - 核糖)合成酶基因的表达抑制干扰素 - γ和佛波酯诱导的HLA - DR及白细胞介素 - 1的产生。
Biochim Biophys Acta. 1992 Apr 30;1135(1):79-83. doi: 10.1016/0167-4889(92)90169-c.
8
Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.II类反式激活因子(CIITA)的表观遗传失活与结肠直肠癌和胃癌细胞中干扰素-γ诱导的HLA-DR表达缺失有关。
Oncogene. 2004 Nov 25;23(55):8876-86. doi: 10.1038/sj.onc.1208144.
9
HLA-D subregion expression by thyroid epithelium in autoimmune thyroid diseases and induced in vitro.自身免疫性甲状腺疾病中甲状腺上皮细胞的HLA - D亚区表达及体外诱导表达
Clin Exp Immunol. 1987 Sep;69(3):532-42.
10
Statins decrease the aberrant HLA-DR expression on thyrocytes from patients with Hashimoto's thyroiditis.他汀类药物可降低桥本甲状腺炎患者甲状腺细胞上异常的HLA - DR表达。
Horm Metab Res. 2008 Dec;40(12):838-41. doi: 10.1055/s-2008-1081500. Epub 2008 Aug 6.